UroGen Pharma Ltd.

Q1 2020 vs. Q1 2023 13F Holders

Period
Q1 2020
Q1 2023
Num holders
85
71
Total reported value, excl. options
$250 M
$116 M
Total shares, excl. options
14,022,384
12,536,155
Manager Q1 2020
Shares
Q1 2023
Shares
Diff Chg %